Friday 15 April 2016

Walk-In Torrent Pharmaceuticals Ltd On 17/04/16 @ Ahmedabad

REFERENCE
Srinivasulu Tirumalasetty
Global pharma News

Walk-In For Torrent Pharmaceuticals Ltd

Here is I am giving information about walk-in Interview in Torrent Pharmaceuticals Ltd.

Job Location: Indrad @ Hotel NAMI Residency, Ahmdabad on 17th April, 2016 (Sunday)

Interview Venue:

Hotel NAMI Residency
Opp. V.S.Hospital,
Ellisbridge,
Ahmedabdad, Gujarat.

Date: 17th April, 2016-Sunday

Time: 10:00 Am to 04:00 PM

Job Location : Ahmedabad (Indrad Plant)

Department: Quality Control

Qualificatoin: B.Sc. / M.Sc./ B.Pharm./ M.Pharm.

Experience: 1-9 YEARS IN rEPUTED pHARMACEUTICAL INDUSTRY

Brief Job Requirements:

Analysis of finished product, stability samples and Raw material as per Method of analysis.
Analytical Method Development, Verification and Validation.
Responsible for preparation of specification and STP, Data interpretation and troubleshooting.
Preparation of method verification protocols and data sheet.
Sound knowledge of HPLC/GC/Dissolution Apparatus/XRPD/DSC/Chemical Analysis.
Important Instruction:
Preference will be given to those,having experience of working in API/ Formulation regulatory approved plants.USFDA, MHRA, ANVISA knowledge will be an added advantage.
Candidates may walk-In for interview having experience of working along with their updated Resume & Passport size Photograph.
Documents Requirement:
Photocopy of all Marksheets, School Leaving certificate, PAN card, Salary slips & Bank Statement (Last six months), Increment letter.

Regards,
Mayur Desai
Human Resources
Torrent Pharmaceuticals Ltd.
Office Line: 9879603921/22/23/24/25
Mobile No: 9909905477

Company Profile:
Torrent Pharmaceuticals Ltd.
The flagship company of the Torrent Group, Torrent Pharmaceuticals Limited is a major player in the Indian pharmaceuticals sector with the vision of becoming a global entity. Torrent Pharma enjoys dominance in the niche therapeutic areas like, cardiovascular and central nervous system, gastro-intestinal, pain management and oral anti-diabetic segments.
Torrent Pharma owes its success in the domestic market to its thrust on frontline research, strategic marketing and world-class manufacturing. It is among the largest spenders on R&D and has set up one of the most advanced research centers in the country at an investment of Rs. 200 crores so far. It has discovered and patented the AGE (Advanced Glycosylation End Product) Breaker Compound which has potential to treat heart diseases and diabetes related vascular complications. Its manufacturing facilities have received quality certifications from various international regulatory authorities.

It is this success that Torrent Pharma attempts to replicate in the international market now. It has already established fully-owned subsidiaries in Australia , Brazil , Germany , Japan , Mexico , Philippines Russia and USA and has over 1000 product registrations in more than 50 countries worldwide

No comments:

Post a Comment